Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic transplantation with thiotepa, busulfan and fludarabine in refractory or early-relapsed aggressive B-cell non-Hodgkin lymphomas
2012-005378-73Phase 2Completed
- Sponsor
- Fondazione EMN Italy
- Start
- Jan 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa, busulfan, fludarabine, cyclosporine, methotrexate in aggressive B-cell lymphoma, mature B-cell lymphoma, sponsored by Fondazione EMN Italy. Started Jan 2013; status: completed.
02
Drugs
thiotepabusulfanfludarabinecyclosporinemethotrexate
03
Conditions
aggressive B-cell lymphomamature B-cell lymphoma
Beyond the preview
Go deeper on 2012-005378-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005378-73.